BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, Satchell SC, Mathieson PW, Obrig TG. Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect Immun 2009;77:959-69. [PMID: 19124603 DOI: 10.1128/IAI.00679-08] [Cited by in Crossref: 57] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Detzner J, Gloerfeld C, Pohlentz G, Legros N, Humpf HU, Mellmann A, Karch H, Müthing J. Structural Insights into Escherichia coli Shiga Toxin (Stx) Glycosphingolipid Receptors of Porcine Renal Epithelial Cells and Inhibition of Stx-Mediated Cellular Injury Using Neoglycolipid-Spiked Glycovesicles. Microorganisms 2019;7:E582. [PMID: 31752441 DOI: 10.3390/microorganisms7110582] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
2 Keir LS, Saleem MA. Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome. Pediatr Nephrol 2014;29:1895-902. [PMID: 23843163 DOI: 10.1007/s00467-013-2561-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ståhl AL, Arvidsson I, Johansson KE, Chromek M, Rebetz J, Loos S, Kristoffersson AC, Békássy ZD, Mörgelin M, Karpman D. A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles. PLoS Pathog 2015;11:e1004619. [PMID: 25719452 DOI: 10.1371/journal.ppat.1004619] [Cited by in F6Publishing: 63] [Reference Citation Analysis]
4 Porubsky S, Federico G, Müthing J, Jennemann R, Gretz N, Büttner S, Obermüller N, Jung O, Hauser IA, Gröne E, Geiger H, Gröne HJ, Betz C. Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure. J Pathol 2014;234:120-33. [PMID: 24909663 DOI: 10.1002/path.4388] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
5 Keir L, Coward RJ. Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatr Nephrol 2011;26:523-33. [PMID: 20949284 DOI: 10.1007/s00467-010-1637-4] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
6 Estrada CC, Cardona S, Guo Y, Revelo MP, D'Agati VD, Koganti S, Devaraj J, He JC, Heeger PS, Mallipattu SK. Endothelial-specific loss of Krüppel-Like Factor 4 triggers complement-mediated endothelial injury. Kidney Int 2022:S0085-2538(22)00344-1. [PMID: 35483525 DOI: 10.1016/j.kint.2022.03.025] [Reference Citation Analysis]
7 Mayer CL, Parello CS, Lee BC, Itagaki K, Kurosawa S, Stearns-Kurosawa DJ. Pro-Coagulant Endothelial Dysfunction Results from EHEC Shiga Toxins and Host Damage-Associated Molecular Patterns. Front Immunol 2015;6:155. [PMID: 25904918 DOI: 10.3389/fimmu.2015.00155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
8 Villysson A, Tontanahal A, Karpman D. Microvesicle Involvement in Shiga Toxin-Associated Infection. Toxins (Basel) 2017;9:E376. [PMID: 29156596 DOI: 10.3390/toxins9110376] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
9 Mohawk KL, O'Brien AD. Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection. J Biomed Biotechnol 2011;2011:258185. [PMID: 21274267 DOI: 10.1155/2011/258185] [Cited by in Crossref: 107] [Cited by in F6Publishing: 94] [Article Influence: 9.7] [Reference Citation Analysis]
10 Johansson K, Willysson A, Kristoffersson AC, Tontanahal A, Gillet D, Ståhl AL, Karpman D. Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor. Front Cell Infect Microbiol 2020;10:212. [PMID: 32523894 DOI: 10.3389/fcimb.2020.00212] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
11 Maruyama H, Taguchi A, Nishikawa Y, Guili C, Mikame M, Nameta M, Yamaguchi Y, Ueno M, Imai N, Ito Y, Nakagawa T, Narita I, Ishii S. Medullary thick ascending limb impairment in the GlatmTg(CAG-A4GALT) Fabry model mice. FASEB J 2018;32:4544-59. [PMID: 29553830 DOI: 10.1096/fj.201701374R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 Thorpe CM, Pulsifer AR, Osburne MS, Vanaja SK, Leong JM. Citrobacter rodentium(ϕStx2dact), a murine infection model for enterohemorrhagic Escherichia coli. Curr Opin Microbiol 2021;65:183-90. [PMID: 34929548 DOI: 10.1016/j.mib.2021.11.013] [Reference Citation Analysis]
13 Amouroux C, Adra AL, Mouba JF, Tenenbaum J, Ichay L, Dalla-Vale F, Milesi C, Morin D. [Hemolytic uremic syndrome with severe neurological involvement: how should it be managed?]. Arch Pediatr 2012;19:150-5. [PMID: 22245485 DOI: 10.1016/j.arcped.2011.11.015] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Sánchez DS, Fischer Sigel LK, Balestracci A, Ibarra C, Amaral MM, Silberstein C. Eliglustat prevents Shiga toxin 2 cytotoxic effects in human renal tubular epithelial cells. Pediatr Res 2021. [PMID: 34155339 DOI: 10.1038/s41390-021-01622-3] [Reference Citation Analysis]
15 Feitz WJC, van Setten PA, van der Velden TJAM, Licht C, van den Heuvel LPJW, van de Kar NCAJ. Cell Biological Responses after Shiga Toxin-1 Exposure to Primary Human Glomerular Microvascular Endothelial Cells from Pediatric and Adult Origin. Int J Mol Sci 2021;22:5615. [PMID: 34070679 DOI: 10.3390/ijms22115615] [Reference Citation Analysis]
16 Burlaka I, Liu XL, Rebetz J, Arvidsson I, Yang L, Brismar H, Karpman D, Aperia A. Ouabain protects against Shiga toxin-triggered apoptosis by reversing the imbalance between Bax and Bcl-xL. J Am Soc Nephrol 2013;24:1413-23. [PMID: 23744887 DOI: 10.1681/ASN.2012101044] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
17 Dennhardt S, Pirschel W, Wissuwa B, Daniel C, Gunzer F, Lindig S, Medyukhina A, Kiehntopf M, Rudolph WW, Zipfel PF, Gunzer M, Figge MT, Amann K, Coldewey SM. Modeling Hemolytic-Uremic Syndrome: In-Depth Characterization of Distinct Murine Models Reflecting Different Features of Human Disease. Front Immunol 2018;9:1459. [PMID: 29988557 DOI: 10.3389/fimmu.2018.01459] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
18 Obrig TG. Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease. Toxins (Basel) 2010;2:2769-94. [PMID: 21297888 DOI: 10.3390/toxins2122769] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 7.3] [Reference Citation Analysis]
19 Mallick EM, Garber JJ, Vanguri VK, Balasubramanian S, Blood T, Clark S, Vingadassalom D, Louissaint C, McCormick B, Snapper SB, Leong JM. The ability of an attaching and effacing pathogen to trigger localized actin assembly contributes to virulence by promoting mucosal attachment. Cell Microbiol 2014;16:1405-24. [PMID: 24780054 DOI: 10.1111/cmi.12302] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
20 Boyer O, Niaudet P. Hemolytic uremic syndrome: new developments in pathogenesis and treatment. Int J Nephrol 2011;2011:908407. [PMID: 21876803 DOI: 10.4061/2011/908407] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
21 Obata F, Subrahmanyam PB, Vozenilek AE, Hippler LM, Jeffers T, Tongsuk M, Tiper I, Saha P, Jandhyala DM, Kolling GL, Latinovic O, Webb TJ. Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice. Front Microbiol 2015;6:262. [PMID: 25904903 DOI: 10.3389/fmicb.2015.00262] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
22 Celi AB, Goldstein J, Rosato-siri MV, Pinto A. Role of Globotriaosylceramide in Physiology and Pathology. Front Mol Biosci 2022;9:813637. [DOI: 10.3389/fmolb.2022.813637] [Reference Citation Analysis]
23 Tesh VL. Activation of cell stress response pathways by Shiga toxins. Cell Microbiol 2012;14:1-9. [PMID: 21899699 DOI: 10.1111/j.1462-5822.2011.01684.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
24 Pinto A, Jacobsen M, Geoghegan PA, Cangelosi A, Cejudo ML, Tironi-Farinati C, Goldstein J. Dexamethasone rescues neurovascular unit integrity from cell damage caused by systemic administration of shiga toxin 2 and lipopolysaccharide in mice motor cortex. PLoS One 2013;8:e70020. [PMID: 23894578 DOI: 10.1371/journal.pone.0070020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
25 Tremblay JM, Mukherjee J, Leysath CE, Debatis M, Ofori K, Baldwin K, Boucher C, Peters R, Beamer G, Sheoran A, Bedenice D, Tzipori S, Shoemaker CB. A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2. Infect Immun 2013;81:4592-603. [PMID: 24082082 DOI: 10.1128/IAI.01033-13] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
26 Obrig TG, Karpman D. Shiga toxin pathogenesis: kidney complications and renal failure. Curr Top Microbiol Immunol 2012;357:105-36. [PMID: 21983749 DOI: 10.1007/82_2011_172] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
27 Bowen EE, Coward RJ. Advances in our understanding of the pathogenesis of hemolytic uremic syndromes. Am J Physiol Renal Physiol. 2018;314:F454-F461. [PMID: 29167171 DOI: 10.1152/ajprenal.00376.2017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
28 DesRochers TM, Kimmerling EP, Jandhyala DM, El-Jouni W, Zhou J, Thorpe CM, Leong JM, Kaplan DL. Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue. Infect Immun 2015;83:28-38. [PMID: 25312954 DOI: 10.1128/IAI.02143-14] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
29 Ochoa F, Oltra G, Gerhardt E, Hermes R, Cohen L, Damiano AE, Ibarra C, Lago NR, Zotta E. Microalbuminuria and early renal response to lethal dose Shiga toxin type 2 in rats. Int J Nephrol Renovasc Dis 2012;5:29-36. [PMID: 22334798 DOI: 10.2147/IJNRD.S27623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
30 Keir LS, Marks SD, Kim JJ. Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies. Drug Des Devel Ther 2012;6:195-208. [PMID: 22888220 DOI: 10.2147/DDDT.S25757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
31 Mallick EM, McBee ME, Vanguri VK, Melton-Celsa AR, Schlieper K, Karalius BJ, O'Brien AD, Butterton JR, Leong JM, Schauer DB. A novel murine infection model for Shiga toxin-producing Escherichia coli. J Clin Invest 2012;122:4012-24. [PMID: 23041631 DOI: 10.1172/JCI62746] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
32 Lee MS, Koo S, Jeong DG, Tesh VL. Shiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic Applications. Toxins (Basel) 2016;8:E77. [PMID: 26999205 DOI: 10.3390/toxins8030077] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 8.8] [Reference Citation Analysis]
33 Trachtman H, Austin C, Lewinski M, Stahl RA. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol 2012;8:658-69. [PMID: 22986362 DOI: 10.1038/nrneph.2012.196] [Cited by in Crossref: 129] [Cited by in F6Publishing: 113] [Article Influence: 12.9] [Reference Citation Analysis]
34 Griener TP, Strecker JG, Humphries RM, Mulvey GL, Fuentealba C, Hancock RE, Armstrong GD. Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2. PLoS One 2011;6:e21457. [PMID: 21731756 DOI: 10.1371/journal.pone.0021457] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
35 Watanabe-Takahashi M, Yamasaki S, Murata M, Kano F, Motoyama J, Yamate J, Omi J, Sato W, Ukai H, Shimasaki K, Ikegawa M, Tamura-Nakano M, Yanoshita R, Nishino Y, Miyazawa A, Natori Y, Toyama-Sorimachi N, Nishikawa K. Exosome-associated Shiga toxin 2 is released from cells and causes severe toxicity in mice. Sci Rep 2018;8:10776. [PMID: 30018364 DOI: 10.1038/s41598-018-29128-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
36 Haddad G, Zhu LF, Rayner DC, Murray AG. Experimental glomerular endothelial injury in vivo. PLoS One 2013;8:e78244. [PMID: 24143262 DOI: 10.1371/journal.pone.0078244] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
37 Dettmar AK, Binder E, Greiner FR, Liebau MC, Kurschat CE, Jungraithmayr TC, Saleem MA, Schmitt CP, Feifel E, Orth-Höller D, Kemper MJ, Pepys M, Würzner R, Oh J. Protection of human podocytes from shiga toxin 2-induced phosphorylation of mitogen-activated protein kinases and apoptosis by human serum amyloid P component. Infect Immun 2014;82:1872-9. [PMID: 24566618 DOI: 10.1128/IAI.01591-14] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
38 Fuller CA, Pellino CA, Flagler MJ, Strasser JE, Weiss AA. Shiga toxin subtypes display dramatic differences in potency. Infect Immun 2011;79:1329-37. [PMID: 21199911 DOI: 10.1128/IAI.01182-10] [Cited by in Crossref: 175] [Cited by in F6Publishing: 97] [Article Influence: 15.9] [Reference Citation Analysis]
39 Obata F, Obrig T. Role of Shiga/Vero toxins in pathogenesis. Microbiol Spectr 2014;2. [PMID: 25530918 DOI: 10.1128/microbiolspec.EHEC-0005-2013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
40 Saleem MA. The phenomenon of focal segmental glomerulosclerosis post-transplantation--a one-hit wonder? Pediatr Nephrol 2012;27:2163-6. [PMID: 22806560 DOI: 10.1007/s00467-012-2218-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]